Medications
Johnson & Johnson's 4Q profit rises 19 percent
Surging sales of Johnson & Johnson's prescription medicines and the rebound of its recall-plagued consumer health business lifted fourth-quarter profit 19 percent.
Jan 21, 2014
0
0
Page 19 - News tagged with share
Health informatics
Informed consent to the use of personal health data: A new standardized approach
For the first time, international initiatives such as the European Health Data Space recognize the value of citizen-generated health data. An EU-wide digital platform will allow the exchange of traditional as well as citizen-generated ...
Nov 16, 2023
0
0
Other
Insurer WellPoint's 3Q net income edges higher
(AP)—WellPoint says its third-quarter net income rose 1 percent, as the nation's second largest health insurer trimmed expenses to balance flat revenue and an enrollment decline.
Nov 7, 2012
0
0
Medications
Mylan, like other generic drugmakers, feels the pricing pain
Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory ...
Aug 9, 2017
0
0
Diseases, Conditions, Syndromes
Opinion: Inquiry must assess how Canada's fragmented COVID-19 response lost the public's trust
Over the course of the pandemic, more than 53,000 Canadians died and nearly five million contracted COVID-19.
Jul 31, 2023
0
1
Medications
Glaxo says China drugs sales slump on bribery probe (Update)
British drugmaker GlaxoSmithKline revealed on Wednesday that pharmaceuticals and vaccines sales in China tumbled 61 percent in the third quarter, as it was rocked by a state bribery probe.
Oct 23, 2013
0
0
Other
Valeant: We'll bump Allergan offer to $200 a share
The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox.
Oct 27, 2014
0
0
Medications
Adamas Pharma rises after IPO raises $48 million
Shares of Adamas Pharmaceuticals rose Thursday after the drug developer's initial public offering raised $48 million.
Apr 10, 2014
0
0
Medical economics
Most research participants not concerned about data sharing
(HealthDay)—Few participants in clinical trials have strong concerns about the risks of data sharing, according to a study published June 7 in the New England Journal of Medicine.
Aug 27, 2018
0
0
Health
Higher concentration of physicians groups could increase costs, researchers say
As physician groups grow larger, their increased market share may drive costs up, rather than down, as they gain bargaining power with insurers, according to a new study by researchers at the Stanford University School of ...
Jun 8, 2015
0
2
